The global Nuclear Medicine Therapeutics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
IBA Group
Lantheus Medical Imaging
Triad Isotopes
Siemens Healthcare (PETNET Solutions)
NTP Radioisotopes
By Types:
Alpha Emitters
Beta Emitters
Brachytherapy
By Applications:
Application I
Application II
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Nuclear Medicine Therapeutics Market Size Analysis from 2023 to 2028
1.5.1 Global Nuclear Medicine Therapeutics Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Nuclear Medicine Therapeutics Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Nuclear Medicine Therapeutics Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Nuclear Medicine Therapeutics Industry Impact
Chapter 2 Global Nuclear Medicine Therapeutics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Nuclear Medicine Therapeutics (Volume and Value) by Type
2.1.1 Global Nuclear Medicine Therapeutics Consumption and Market Share by Type (2017-2022)
2.1.2 Global Nuclear Medicine Therapeutics Revenue and Market Share by Type (2017-2022)
2.2 Global Nuclear Medicine Therapeutics (Volume and Value) by Application
2.2.1 Global Nuclear Medicine Therapeutics Consumption and Market Share by Application (2017-2022)
2.2.2 Global Nuclear Medicine Therapeutics Revenue and Market Share by Application (2017-2022)
2.3 Global Nuclear Medicine Therapeutics (Volume and Value) by Regions
2.3.1 Global Nuclear Medicine Therapeutics Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Nuclear Medicine Therapeutics Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Nuclear Medicine Therapeutics Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Nuclear Medicine Therapeutics Consumption by Regions (2017-2022)
4.2 North America Nuclear Medicine Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Nuclear Medicine Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Nuclear Medicine Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Nuclear Medicine Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Nuclear Medicine Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Nuclear Medicine Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Nuclear Medicine Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Nuclear Medicine Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.10 South America Nuclear Medicine Therapeutics Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Nuclear Medicine Therapeutics Market Analysis
5.1 North America Nuclear Medicine Therapeutics Consumption and Value Analysis
5.1.1 North America Nuclear Medicine Therapeutics Market Under COVID-19
5.2 North America Nuclear Medicine Therapeutics Consumption Volume by Types
5.3 North America Nuclear Medicine Therapeutics Consumption Structure by Application
5.4 North America Nuclear Medicine Therapeutics Consumption by Top Countries
5.4.1 United States Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
5.4.2 Canada Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
5.4.3 Mexico Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
Chapter 6 East Asia Nuclear Medicine Therapeutics Market Analysis
6.1 East Asia Nuclear Medicine Therapeutics Consumption and Value Analysis
6.1.1 East Asia Nuclear Medicine Therapeutics Market Under COVID-19
6.2 East Asia Nuclear Medicine Therapeutics Consumption Volume by Types
6.3 East Asia Nuclear Medicine Therapeutics Consumption Structure by Application
6.4 East Asia Nuclear Medicine Therapeutics Consumption by Top Countries
6.4.1 China Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
6.4.2 Japan Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
6.4.3 South Korea Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
Chapter 7 Europe Nuclear Medicine Therapeutics Market Analysis
7.1 Europe Nuclear Medicine Therapeutics Consumption and Value Analysis
7.1.1 Europe Nuclear Medicine Therapeutics Market Under COVID-19
7.2 Europe Nuclear Medicine Therapeutics Consumption Volume by Types
7.3 Europe Nuclear Medicine Therapeutics Consumption Structure by Application
7.4 Europe Nuclear Medicine Therapeutics Consumption by Top Countries
7.4.1 Germany Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
7.4.2 UK Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
7.4.3 France Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
7.4.4 Italy Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
7.4.5 Russia Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
7.4.6 Spain Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
7.4.7 Netherlands Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
7.4.8 Switzerland Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
7.4.9 Poland Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
Chapter 8 South Asia Nuclear Medicine Therapeutics Market Analysis
8.1 South Asia Nuclear Medicine Therapeutics Consumption and Value Analysis
8.1.1 South Asia Nuclear Medicine Therapeutics Market Under COVID-19
8.2 South Asia Nuclear Medicine Therapeutics Consumption Volume by Types
8.3 South Asia Nuclear Medicine Therapeutics Consumption Structure by Application
8.4 South Asia Nuclear Medicine Therapeutics Consumption by Top Countries
8.4.1 India Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
8.4.2 Pakistan Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Nuclear Medicine Therapeutics Market Analysis
9.1 Southeast Asia Nuclear Medicine Therapeutics Consumption and Value Analysis
9.1.1 Southeast Asia Nuclear Medicine Therapeutics Market Under COVID-19
9.2 Southeast Asia Nuclear Medicine Therapeutics Consumption Volume by Types
9.3 Southeast Asia Nuclear Medicine Therapeutics Consumption Structure by Application
9.4 Southeast Asia Nuclear Medicine Therapeutics Consumption by Top Countries
9.4.1 Indonesia Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
9.4.2 Thailand Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
9.4.3 Singapore Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
9.4.4 Malaysia Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
9.4.5 Philippines Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
9.4.6 Vietnam Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
9.4.7 Myanmar Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
Chapter 10 Middle East Nuclear Medicine Therapeutics Market Analysis
10.1 Middle East Nuclear Medicine Therapeutics Consumption and Value Analysis
10.1.1 Middle East Nuclear Medicine Therapeutics Market Under COVID-19
10.2 Middle East Nuclear Medicine Therapeutics Consumption Volume by Types
10.3 Middle East Nuclear Medicine Therapeutics Consumption Structure by Application
10.4 Middle East Nuclear Medicine Therapeutics Consumption by Top Countries
10.4.1 Turkey Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
10.4.3 Iran Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
10.4.5 Israel Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
10.4.6 Iraq Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
10.4.7 Qatar Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
10.4.8 Kuwait Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
10.4.9 Oman Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
Chapter 11 Africa Nuclear Medicine Therapeutics Market Analysis
11.1 Africa Nuclear Medicine Therapeutics Consumption and Value Analysis
11.1.1 Africa Nuclear Medicine Therapeutics Market Under COVID-19
11.2 Africa Nuclear Medicine Therapeutics Consumption Volume by Types
11.3 Africa Nuclear Medicine Therapeutics Consumption Structure by Application
11.4 Africa Nuclear Medicine Therapeutics Consumption by Top Countries
11.4.1 Nigeria Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
11.4.2 South Africa Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
11.4.3 Egypt Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
11.4.4 Algeria Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
11.4.5 Morocco Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
Chapter 12 Oceania Nuclear Medicine Therapeutics Market Analysis
12.1 Oceania Nuclear Medicine Therapeutics Consumption and Value Analysis
12.2 Oceania Nuclear Medicine Therapeutics Consumption Volume by Types
12.3 Oceania Nuclear Medicine Therapeutics Consumption Structure by Application
12.4 Oceania Nuclear Medicine Therapeutics Consumption by Top Countries
12.4.1 Australia Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
12.4.2 New Zealand Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
Chapter 13 South America Nuclear Medicine Therapeutics Market Analysis
13.1 South America Nuclear Medicine Therapeutics Consumption and Value Analysis
13.1.1 South America Nuclear Medicine Therapeutics Market Under COVID-19
13.2 South America Nuclear Medicine Therapeutics Consumption Volume by Types
13.3 South America Nuclear Medicine Therapeutics Consumption Structure by Application
13.4 South America Nuclear Medicine Therapeutics Consumption Volume by Major Countries
13.4.1 Brazil Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
13.4.2 Argentina Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
13.4.3 Columbia Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
13.4.4 Chile Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
13.4.5 Venezuela Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
13.4.6 Peru Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
13.4.8 Ecuador Nuclear Medicine Therapeutics Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Nuclear Medicine Therapeutics Business
14.1 IBA Group
14.1.1 IBA Group Company Profile
14.1.2 IBA Group Nuclear Medicine Therapeutics Product Specification
14.1.3 IBA Group Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Lantheus Medical Imaging
14.2.1 Lantheus Medical Imaging Company Profile
14.2.2 Lantheus Medical Imaging Nuclear Medicine Therapeutics Product Specification
14.2.3 Lantheus Medical Imaging Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Triad Isotopes
14.3.1 Triad Isotopes Company Profile
14.3.2 Triad Isotopes Nuclear Medicine Therapeutics Product Specification
14.3.3 Triad Isotopes Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Siemens Healthcare (PETNET Solutions)
14.4.1 Siemens Healthcare (PETNET Solutions) Company Profile
14.4.2 Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Product Specification
14.4.3 Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 NTP Radioisotopes
14.5.1 NTP Radioisotopes Company Profile
14.5.2 NTP Radioisotopes Nuclear Medicine Therapeutics Product Specification
14.5.3 NTP Radioisotopes Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Nuclear Medicine Therapeutics Market Forecast (2023-2028)
15.1 Global Nuclear Medicine Therapeutics Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Nuclear Medicine Therapeutics Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Nuclear Medicine Therapeutics Value and Growth Rate Forecast (2023-2028)
15.2 Global Nuclear Medicine Therapeutics Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Nuclear Medicine Therapeutics Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Nuclear Medicine Therapeutics Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Nuclear Medicine Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Nuclear Medicine Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Nuclear Medicine Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Nuclear Medicine Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Nuclear Medicine Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Nuclear Medicine Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Nuclear Medicine Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Nuclear Medicine Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Nuclear Medicine Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Nuclear Medicine Therapeutics Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Nuclear Medicine Therapeutics Consumption Forecast by Type (2023-2028)
15.3.2 Global Nuclear Medicine Therapeutics Revenue Forecast by Type (2023-2028)
15.3.3 Global Nuclear Medicine Therapeutics Price Forecast by Type (2023-2028)
15.4 Global Nuclear Medicine Therapeutics Consumption Volume Forecast by Application (2023-2028)
15.5 Nuclear Medicine Therapeutics Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Request Sample 
Request Discount 
Inquire Before Buy
